US gene discovery leads to patent war

The finding of the association of a human gene with breast cancer has suddenly turned into a patent war in the US. Myriad Genetics, the Utah biotechnology firm that in 1994 isolated the BRCA1 gene that is strongly associated with breast cancer, is now seeking to patent the gene. The company says that it will soon begin selling a test kit for $900 (£590) that will show …